Merck & Co., Inc.  

(Public, NYSE:MRK)   Watch this stock  
Find more results for MRK
48.84
-0.54 (-1.09%)
After Hours: 48.83 -0.01 (-0.02%)
Feb 8, 5:07PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 47.97 - 49.33
52 week 45.69 - 61.70
Open 48.93
Vol / Avg. 13.35M/12.46M
Mkt cap 138.65B
P/E 31.24
Div/yield 0.46/3.77
EPS 1.56
Shares 2.79B
Beta 0.65
Inst. own 75%
May 5, 2016
Q1 2016 Merck & Co Inc Earnings Release - 9:30AM EDT - Add to calendar
May 5, 2016
Q1 2016 Merck & Co Inc Earnings Call - 8:00AM EDT - Add to calendar
Feb 3, 2016
Q4 2015 Merck & Co Inc Earnings Release
Feb 3, 2016
Q4 2015 Merck & Co Inc Earnings Call - Webcast
Jan 11, 2016
Merck & Co Inc at JPMorgan Healthcare Conference - Webcast
Jan 5, 2016
Merck & Co Inc at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2014
Net profit margin 9.61% 28.25%
Operating margin 16.83% 39.85%
EBITD margin - 52.25%
Return on average assets - 11.70%
Return on average equity - 24.22%
Employees 70,000 -
CDP Score - 88 B

Address

2000 Galloping Hill Rd
KENILWORTH, NJ 07033-1310
United States - Map
+1-908-7404000 (Phone)
+1-908-4231987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures. The Company’s Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines. The Company’s animal health products are sold to veterinarians, distributors and animal producers.

Officers and directors

Kenneth C. Frazier Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert M. Davis Chief Financial Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
Clark Golestani Executive Vice President, Chief Information Officer
Age: 48
Bio & Compensation  - Reuters
Michael J. Holston Executive Vice President, Chief Ethics and Compliance Officer, General Counsel
Age: 52
Bio & Compensation  - Reuters
Mirian M. Graddick-Weir Executive Vice President - Human Resources
Age: 60
Bio & Compensation  - Reuters
Willie A. Deese Executive Vice President, President - Merck Manufacturing Division
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Richard R. DeLuca Jr. Executive Vice President, President - Merck Animal Health
Age: 52
Bio & Compensation  - Reuters
Julie Louise Gerberding Executive Vice President - Strategic Communications, Global Public Policy & Population Health
Age: 59
Bio & Compensation  - Reuters
Roger M. Perlmutter M.D., Ph.D. Executive Vice President, President - Merck Research Laboratories
Age: 63
Bio & Compensation  - Reuters
Michael Rosenblatt M.D. Executive Vice President, Chief Medical Officer
Age: 67
Bio & Compensation  - Reuters